Allianz Biosciences Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2003.
2003 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Allianz Biosciences Private Limited

Allianz Biosciences Private Limited, a active private limited company, was established on 17 January 2003 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TN2003PTC050203. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹7.00 M and a paid-up capital of ₹5.50 M.

Formerly known as Healkraft Remedies (India) Private Limited. It upholds a compliant status. Employing 123 professional, Its leadership includes Srinivasan Balamurugan (Director), Murugesan Senthil Kumar (Whole-Time Director). Past directors included Venkata Krishna Murty Ponnapalli, Raghavan Srinivasa Ranganathan, Hiralal Goud. It holds ₹4.80 Cr open charges and ₹1.00 M settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Block No. 14, R.A. Building, Iii Floor, Old No. 19, New No. 72, Marshalls Road,, Egmore,, Chennai, Tamil Nadu, 600008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TN2003PTC050203

  • Registration Number

    050203

  • Incorporation Date

    17 January 2003

  • Authorized Capital

    ₹7.00 M

  • Paid-Up Capital

    ₹5.50 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.00 M
  • Paid Up Capital ₹ 5.50 M
  • Company Age 23 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.80 Cr
  • Satisfied Charges ₹ 1.00 M
  • Revenue Growth **** 30.23%
  • Profit Growth **** 45.64%
  • Ebitda **** 58.31%
  • Net Worth 0.85%
  • Total Assets -0.95%
Company report

Allianz Biosciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Allianz Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Allianz Biosciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Srinivasan Balamurugan Director 23 Oct 2019 Current
Murugesan Senthil Kumar Whole-Time Director 08 Jul 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Oct 2019 Past
Pramod Abcsdd Director 31 Mar 2020 Past
Pramod Abcsdd Director 08 Jul 2009 Past
Pramod Abcsdd Manager 25 Jun 2013 Past
Pramod Abcsdd Additional Director 26 Dec 2020 Past
Pramod Abcsdd Director 01 Nov 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Allianz Biosciences.

Allianz Biosciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.23% increase. The company also saw a substantial improvement in profitability, with a 45.64% increase in profit. The company's net worth moved up by a moderate rise of 0.85%.

Allianz Biosciences revenue growth over time
Allianz Biosciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 30.23%
*******
*******
*******
*******
Revenue from Operations
*******
 29.13%
*******
*******
*******
*******
Total Assets
*******
 -0.95%
*******
*******
*******
*******
Profit or Loss
*******
 45.64%
*******
*******
*******
*******
Net Worth
*******
 0.85%
*******
*******
*******
*******
EBITDA
*******
 58.31%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Allianz Biosciences?

In 2022, Allianz Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹48,000,000.00

Satisfied Charges

₹1,000,000.00

Charges Breakdown by Lending Institutions
  • Citi Bank N.A. : 4.80 Cr
Latest Charge Details
Date Lender Amount Status
20 Jul 2011 Citi Bank N.A. ₹4.80 Cr Open
10 Feb 2020 State Bank Of India ₹1.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Allianz Biosciences?

Allianz Biosciences has a workforce of 123 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Allianz Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allianz Biosciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Allianz Biosciences
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 10 Feb 2020 via Charge ID 100328743 with State Bank Of India was fully satisfied on 10 Nov 2025. was completed.

  • Annual General Meeting

    The activity Allianz Biosciences Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Allianz Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.

  • Charges

    A charge with Citi Bank N.A. of Rs. 48.00 M registered on 20 Jul 2011 with Charge ID 10303858 was modified on 05 Jun 2023. was recorded as a recent event.

  • Charges

    A charge with State Bank Of India amounted to Rs. 1.00 M with Charge ID 100328743 was registered on 10 Feb 2020. was recorded as a recent event.

  • Director Appointment

    Srinivasan Balamurugan was appointed as a Director was appointed as a Director on 23 Oct 2019 & has been associated with this company since 6 years 4 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Allianz Biosciences Private Limited?

The CIN of Allianz Biosciences Private Limited is U24231TN2003PTC050203.

Where is Allianz Biosciences Private Limited headquartered?

Allianz Biosciences Private Limited is headquartered at Block No. 14, R.A. Building, Iii Floor, Old No. 19, New No. 72, Marshalls Road,, Egmore,, Chennai, Tamil Nadu, 600008.

When was Allianz Biosciences Private Limited incorporated?

Allianz Biosciences Private Limited was incorporated on 17 January 2003.

Who are the current directors of Allianz Biosciences Private Limited?

The current directors of Allianz Biosciences Private Limited are

What is the primary industry of Allianz Biosciences Private Limited?

The primary industry of Allianz Biosciences Private Limited is Manufacturing.

Is Allianz Biosciences Private Limited a listed company?

Allianz Biosciences Private Limited is unlisted.

What is the capital structure of Allianz Biosciences Private Limited?

The authorized capital of Allianz Biosciences Private Limited is ₹7.00 M, and the paid-up capital is ₹5.50 M.

What is the compliance status of Allianz Biosciences Private Limited?

The compliance status of Allianz Biosciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available